Our mucOne antibodies bind to cell lines displaying tumor-specific glycosylation. Their sequence diversity enables distinct binding characteristics, enhancing targeting precision

Our mucOne IgG antibodies specifically target the tumor-associated glycoform of MUC1, avoiding cross-reactivity with other glycoproteins sharing the same glycoform

Immunohistochemistry with mucOne IgG selectively stains cancer tissues (i) expressing the tumor-specific MUC1 glycoform, with no reactivity in healthy tissues (ii)